Literature DB >> 34282304

Adjuvant olaparib - should all patients with breast cancer have genetic testing?

Steven A Narod1.   

Abstract

Entities:  

Year:  2021        PMID： 34282304     DOI： 10.1038/s41571-021-00544-7

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing.

Authors:  Lesley Fallowfield; Ivonne Solis-Trapala; Rachel Starkings; Shirley May; Lucy Matthews; Diana Eccles; D Gareth Evans; Clare Turnbull; Gillian Crawford; Valerie Jenkins
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.